Naomi Girma and the Unfinished Million-Dollar Deal: Chelsea, the USWNT and the Math Sitting on the Bench

On October 13, on the turf in Chester, Pennsylvania, the United States Women's National Team walks out for the second of two friendlies against Spain — the reigning World Cup champion and current world No. 1. The story worth telling lies in an absence named Naomi Girma. The centerback Emma Hayes calls "the best defender I've ever seen" will not play, sidelined by a calf problem that keeps recurring since January 2026. Also missing is Sam Coffey, the starting defensive midfielder, with an ankle issue. Ahead of them stands Spain — a side Hayes herself admits will test the U.S. "in every way" through its "tactical sophistication." The stakes reach far beyond an ordinary friendly. This is the opening stress test of an entire World Cup cycle.

I have followed the women's transfer market long enough to know a deal is never just a number on paper. In January 2026, Chelsea signed Girma for a fee reported at one million dollars — the first seven-figure transfer in the history of women's football. At the time, it was a statement. Chelsea positioned itself as the market leader, pulling elite American talent into the WSL.

To understand why one million dollars matters, place it against the historical backdrop. For decades, women's football was systematically undervalued. Transfers often sat in the tens of thousands, or at zero, with players moving as free agents. When Chelsea broke the seven-figure barrier, they didn't merely buy a player — they set a benchmark. Every such benchmark carries an expectation: that the market will follow, that the value of women players will be seen more accurately.

Ten months later, the picture looks different. Girma played ten league games last season and none this season. For a centerback on a record fee, that utilization rate is alarming. Girma's quality is beyond doubt — she is a top-tier defender and an elite deep organizer. What's missing is availability. At the highest level, a good player who cannot take the pitch is an asset losing value with every matchday.

On the national-team side, the context is even clearer. The U.S. enters a new cycle as the 2026 Olympic gold medalist, under Hayes — a coach with seven league titles at Chelsea. The two Spain fixtures were described by Hayes herself as "essential" World Cup preparation. When both the first-choice centerback and the first-choice defensive midfielder are absent in the same window, the defensive structure is carved open along the central spine — exactly where a possession-dominant side like Spain always aims.

This is where I want to slow down, because the financial story and the tactical story are, in truth, one and the same.

From a financial angle, Girma's million-dollar deal carries two layers of value. The first is on-pitch value — a world-class centerback. The second is market-signal value — Chelsea positioning itself as the pioneer of the seven-figure era in women's football. The second layer still holds. But the first is being eroded by injury. When a player suffers recurring calf problems across two seasons, the club isn't just paying wages for a squad slot — it is paying for a void. In the language of sports finance, that is a dormant asset: costs keep running, recovery value sits near zero.

And this is the point I always stress when analyzing deals: injury risk is not a secondary variable — it is the dominant one. For a player in her peak phase, each injury doesn't just remove minutes; it erodes potential resale value and commercial value. A record centerback who cannot take the field will soon be labeled "talented but unavailable" — a sticky tag that is very hard to shake.

Tactically, the problem is graver still. The U.S. loses both its deepest organizer and the screen in front of the back line at once. Girma reads situations and covers behind her teammates. Coffey is the second ball-winner, shielding the central corridor. Losing both means the defense faces Spain without its leader and without its protector. Against the world's No. 1 possession side, that is close to opening the door wide.

More striking is the experience asymmetry among the replacements. Kate Del Fava, Girma's replacement, received her first-ever international call-up at any level only in June, at U23 level. Jaelin Howell returns after nearly a year out of the squad. Facing the world No. 1 in a heavily covered friendly is a harsh environment for players with limited senior minutes. The risk concentrates in the defensive third — the third the U.S. needs most solid.

Based on my experience watching matches, I have seen teams lose both a centerback and a defensive midfielder at once, and their responses usually reveal two paths: dropping into a compact block to protect an inexperienced centerback pairing, or pushing high to press and reduce the time the ball reaches the opponent's feet. Both carry a price. Sitting deep means ceding territory to Spain — a side that needs no invitation to control possession. Pressing high means exposing the space behind the back line, where Girma is usually the one patching gaps. Neither option is clean.

What's interesting is that Hayes herself stated her philosophy plainly: "I've been so insistent on developing bigger numbers." That is a structural statement, not an excuse for injuries. It acknowledges that a small core of elite players cannot absorb an ever-congested calendar. Women's football is entering a phase where the number of matches grows faster than the medical and sports-science systems around it. Depth then becomes a survival condition, not a luxury.

I still remember how the 2026 pandemic shock broke the FFP spreadsheet but could not break the relationships built beforehand. Girma's story takes that shape: it is not merely an injury case, but a test of the club–country relationship in an era when women players cross borders more than ever.

There is a blind spot the official narrative leaves unspoken, and it sits in Hayes' own wording.

"We are working closely with Chelsea to think differently," she said. The phrase "think differently" is worth far more than it appears. It implicitly admits that the current approach — the club-and-country rehabilitation and load-management protocol — has a problem. When a record signing suffers recurring soft-tissue injuries, the question reaches beyond whether the player is durable — it touches who decides how much she trains, how she recovers, and when she returns.

This is the grey zone between club and country — where no hard rule clearly assigns responsibility. FIFA has a player-protection mechanism for injuries sustained on international duty, but that mechanism does not answer the question of long-term load management. When a player turns out for a European club and a national team on another continent, overlapping calendars and differing recovery protocols become a recipe for recurrence.

And there is a detail rarely mentioned: Hayes coached Chelsea for more than a decade before taking over the U.S. national team. This makes coordination smoother — she understands the club culture and its people. But it also raises a question of objectivity. When a national-team coach has a deep historical relationship with the club managing her player, the line between "coordinating for the player" and "coordinating for one side's interest" blurs. There is no violation here. But in this profession, I have learned that what goes unsaid often matters more than what is declared. The stadium corridor taught me one thing: there, a whisper is always truer than applause.

Hayes' handling of the media is equally notable. She keeps lowering expectations: "I haven't, for one minute, ever had the best available squad." She pre-empts the "why is this player called up" question. She talks about developing bigger numbers. This is deliberate expectation-lowering communication — a shield for a development-focused window. But it also shows she anticipates external criticism of how the national team manages injuries. When a coach keeps talking about player welfare, it is usually because they know the question will be asked.

One more angle deserves attention: Girma's move from the U.S. to Europe is no isolated case. Every contract is a love story — some come for the money, some come for the place that loves them. As elite American women's talent increasingly chooses the WSL as its destination, the flow of talent away from the NWSL becomes a trend. That elevates the English women's game, but it also creates new club-versus-country tension — European calendars grow denser, while national teams still need healthy players for international windows.

The two Spain fixtures will decide no standings. But they may shape a narrative: whether the U.S. has enough depth to absorb the absence of its pillars. For Girma, the bigger question isn't whether she is talented — everyone knows that. What remains open is whether she can stay on the pitch long enough for the million-dollar deal to become a success story, rather than a sad footnote about the gap between market value and actual playing time.

Behind every line of numbers is a person. Girma was described as "absolutely devastated" when injury struck again. So was Coffey. Hasty news fades. Patient sources always reach the finish line first. And sometimes the real story isn't who plays on October 13, but who will still be standing when the World Cup cycle closes.